Skip to main content
Gail Roboz, MD, Oncology, New York, NY

Gail J Roboz MD

Oncology•New York, NY

Hematologic Oncology

Associate Professor, Medicine, Weill Cornell Medical College

Request appointment

  • 525 E 68th StNew York, NY 10065

  • Book by Phone+1(417) 574-3251

  • Fax+1 212-746-3305

Overview of  Dr. Roboz

Dr. Gail Roboz is an oncologist in New York, NY and is affiliated with New York-Presbyterian Hospital. She received her medical degree from Icahn School of Medicine at Mount Sinai and has been in practice 32 years. Dr. Roboz accepts several types of health insurance, listed below. She is one of 403 doctors at New York-Presbyterian Hospital who specialize in Oncology. She has more than 100 publications and over 500 citings.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1997 - 2000
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1995 - 1997
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1994 - 1995
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 1994

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1995 - 2028
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2014, 2016-2017
  • Top Doctors: New York Metro Area Castle Connolly, 2012-2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Somatic Mutations Precede Acute Myeloid Leukemia Years Before Diagnosis  
    Sangmin Lee, Pinkal Desai, Gail J Roboz, Ellen K Ritchie, Nature
  • Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML  
    Daniel A Pollyea, Amir T Fathi, Geoffrey L Uy, Robert K Stuart, Mikkael A Sekeres, Courtney D DiNardo, Alice S Mims, Eyal C Attar, Richard M Stone, Hagop M Kantarjian,..., The New England Journal of Medicine

Abstracts/Posters

  • CPX-351 As First Intensive Therapy for Elderly Patients with AML
    Gail J. Roboz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Pharmacokinetic Exposure Equivalence and Preliminary Efficacy and Safety from a Randomized Cross over Phase 3 Study (ASCERTAIN study) of an Oral Hypomethylating Agent ...
    Gail J. Roboz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Landmark Response and Survival Analyses from 206 AML Patients Treated with Guadecitabine in a Phase 2 Study Demonstrate the Importance of Adequate Treatment Duration t...
    Gail J. Roboz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Minimal Residual Disease in Hematologic Malignancies: Testing Considerations and Challenges 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Results from a Global Randomized Phase 3 Study of Guadecitabine (G) Vs Treatment Choice (TC) in 815 Patients with Treatment Na¥ve (TN) AML Unfit for Intensive Chemothe... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Ivosidenib (IVO; AG-120) in IDH1-mutant newly-diagnosed acute myeloid leukemia (ND AML): Updated results from a phase 1 study. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • AML Highlights from EHA 2025
    AML Highlights from EHA 2025September 2nd, 2025
  • Biostate AI and Weill Cornell Medicine Collaborate to Develop AI Models for Personalized Leukemia Care
    Biostate AI and Weill Cornell Medicine Collaborate to Develop AI Models for Personalized Leukemia CareApril 22nd, 2025
  • MRD and Relapse in Patients with AML
    MRD and Relapse in Patients with AMLAugust 17th, 2022

Professional Memberships

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS California CaliforniaCare HMO
    BCBS California PowerSelect HMO
    BCBS California PPO
    BCBS Illinois PPO
    Blue Shield California HMO
    Blue Shield California PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    GHI PPO
    Great West PPO
    Health Net California Large Group PPO
    Health Net HMO - Employer Group
    HIP of New York - Select PPO
    Humana ChoiceCare Network PPO
    MagnaCare PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    Pacificare HMO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
    WEA Trust Preferred Provider Plan - Trust Pref
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Gail Roboz, Dr. Gail Roboz, MD, Dr. G Roboz, Dr. Gail J Roboz